Literature DB >> 6021213

In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

P G Quie, J G White, B Holmes, R A Good.   

Abstract

Diminished bactericidal capacity was found to be characteristic of polymorphonuclear leukocytes (PMN) from five children with the clinical syndrome of granulomatous disease of childhood. The PMN from these children demonstrated nearly normal phagocytic capacity, and the majority of viable bacteria, after 2 hours of incubation in the phagocytosis system, were found associated with leukocytes. The morphology of the unstimulated polymorphonuclear leukocytes from patients with chronic granulomatous disease was similar to those from normal persons of similar ages by light and electron microscopy. In addition, the total lysozyme and phagocytin activity of leukocyte extracts from these patients was similar to those from equal numbers of leukocytes from controls.A striking difference in the cytoplasmic response after phagocytosis characterized the PMN of the patients with granulomatous disease. Whereas degranulation, vacuole formation, and rapid bacterial digestion were the rule in the PMN from controls, little degranulation and persistence of intact bacteria in the cytoplasm characterized disease. The deficiency of bactericidal capacity and the minimal degranulation after active phagocytosis by the PMN of these children with an inherited syndrome suggest that separate metabolic processes are involved in phagocytosis and in intracellular digestion. Continuing study of the metabolic function of leukocytes from these children should provide an opportunity for increased understanding of the metabolic basis for degranulation and intracellular digestion in phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6021213      PMCID: PMC442050          DOI: 10.1172/JCI105568

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM.

Authors:  J G HIRSCH; B STRAUSS
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

2.  THIRTEEN BOYS WITH PROGRESSIVE SEPTIC GRANULOMATOSIS.

Authors:  M J CARSON; D L CHADWICK; C A BRUBAKER; R S CLELAND; B H LANDING
Journal:  Pediatrics       Date:  1965-03       Impact factor: 7.124

3.  Contribution of serum and cellular factors in host defense reactions. II. Cellular factors in host resistance.

Authors:  Z A COHN; K F AUSTEN
Journal:  N Engl J Med       Date:  1963-05-09       Impact factor: 91.245

4.  A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome.

Authors:  R A BRIDGES; H BERENDES; R A GOOD
Journal:  AMA J Dis Child       Date:  1959-04

5.  A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes.

Authors:  B H LANDING; H S SHIRKEY
Journal:  Pediatrics       Date:  1957-09       Impact factor: 7.124

6.  The measurement of lysozyme activity and the ultra-violet inactivation of lysozyme.

Authors:  D SHUGAR
Journal:  Biochim Biophys Acta       Date:  1952-03

7.  The influence of phagocytosis on the intracellular distribution of granule-associated components of polymorphonuclear leucocytes.

Authors:  Z A COHN; J G HIRSCH
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307

8.  Further studies on preparation and properties of phagocytin.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1960-03-01       Impact factor: 14.307

9.  The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes.

Authors:  Z A COHN; J G HIRSCH
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307

10.  Interactions between rabbit polymorphonuclear leucocytes and staphylococci.

Authors:  Z A COHN; S I MORSE
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more
  231 in total

Review 1.  Chronic granulomatous disease.

Authors:  D Goldblatt; A J Thrasher
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Effect of pneumococci on blood clotting, platelets, and polymorphonuclear leukocytes.

Authors:  J C Guckian
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

3.  [Granulocyte dysfunction. Part II. Secondary defects. (authors transl)].

Authors:  D Niethammer; A Wildfeuer; E Kleihauer; O Haferkamp
Journal:  Klin Wochenschr       Date:  1975-08-15

Review 4.  Assembly of the phagocyte NADPH oxidase.

Authors:  William M Nauseef
Journal:  Histochem Cell Biol       Date:  2004-08-04       Impact factor: 4.304

5.  Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease.

Authors:  D G Nathan; R L Baehner; D K Weaver
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

6.  Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.

Authors:  Saskia B Wortmann; Johan L K Van Hove; Terry G J Derks; Nathalie Chevalier; Vijaya Knight; Andreas Koller; Esmee Oussoren; Johannes A Mayr; Francjan J van Spronsen; Florian B Lagler; Sommer Gaughan; Emile Van Schaftingen; Maria Veiga-da-Cunha
Journal:  Blood       Date:  2020-08-27       Impact factor: 22.113

7.  Outer membrane mutants of Salmonella typhimurium LT2 have lipopolysaccharide-dependent resistance to the bactericidal activity of anaerobic human neutrophils.

Authors:  N Okamura; J K Spitznagel
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  D P Speert; F Eftekhar; M L Puterman
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

9.  Transfer factor therapy in hyperimmunoglobulinaemia E syndrome.

Authors:  H H Kesarwala; R V Prasad; R Szep; E Oldman; S Lane; P S Papageorgiou
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

10.  [Effect of open heart surgery on the defense mechanisms against bacterial infections].

Authors:  R Morisset; O Agbaba; R Beaudet; A Adrien
Journal:  Can Med Assoc J       Date:  1977-02-05       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.